There were 27 press releases posted in the last 24 hours and 155,581 in the last 365 days.

Dr. Whitney Hovenic of Skin Cancer & Dermatology Institute Announces the Acquisition of the Vbeam® Prima Laser System

The new Vbeam Prima platform takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) to the next level

RENO, Nev., June 13, 2019 (GLOBE NEWSWIRE) -- Dr. Whitney Hovenic of Skin Cancer & Dermatology Institute in Reno, NV announces the acquisition of the Vbeam® PrimaTM Laser System by Candela, an advanced 595 nm pulsed dye laser (PDL). With the addition of a 1064 nm wavelength and a number of other new features, the Vbeam Prima device will effectively treat a broad range of skin conditions, including rosacea, port wine stains, acne, facial, leg and spider veins, scars, benign pigmented lesions and wrinkles, warts, stretch marks and photo aging. ­

“In a clinical study1 using the Vbeam Prima laser system, facial redness and rosacea symptoms were significantly reduced from moderate to mild after four treatments,” said Dr. Hovenic. “I am extremely excited about the new enhancements, especially the 50% greater power enabling a 15 mm spot size, both contact and spray cooling, once-a-day calibration and extended dye life thanks to a complete re-design,” Dr. Hovenic added.

The Vbeam device is a highly efficient PDL used by healthcare providers all over the world to treat a variety of indications for both face and body with high patient tolerability and a low incidence of side effects. The Vbeam laser has been long considered the “gold standard” for the device based treatment of rosacea, and has also been successfully used for the treatment of port wine stains and vascular anomalies in infants, as well as adults. It is currently used in nearly 700 universities and hospitals worldwide, and has been included in hundreds of medical publications. The new Vbeam Prima laser system builds on that legacy of success by offering advanced features that will help physicians and their patients achieve better results, along with an improved treatment experience.

Skin Cancer & Dermatology Institute’s very own Physicians as well as their trained & licensed Laser Technicians will begin treating clients using the Vbeam Prima laser system in Spring, 2019. To schedule a consultation, please contact Mary Kitchen at 775-336-3645.

For more information about Dr. Whitney Hovenic, please visit https://skincancerderm.com/team/
For more information about the Vbeam Prima laser system, please visit https://candelamedical.com/na  

Skin Cancer & Dermatology Institute
Our team of specialists, including the only fellowship-trained Mohs surgeons in the area, is dedicated to knowing each patient individually and to providing that patient with a holistic approach to healthy skin. As Skin Cancer and Dermatology Institute, we are able to meet all dermatological needs, including general, medical and cosmetic. Our long-standing reputation for being the premiere dermatological center in Nevada is rooted in this level of advanced patient-centered care.

Candela®
Candela is a leading global medical aesthetic device company with an extensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical aesthetic applications including hair removal, wrinkle reduction, tattoo removal, women's health treatments, facial resurfacing, traumatic and surgical scar treatments, body contouring, improving the skin's appearance through the treatment of benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Candela has a wide portfolio of trusted, leading products, including Vbeam®, the Gentle Family®, CO2RE®, CO2RE Intima®, Profound®, elōs Plus®, PicoWay®, UltraShape®, VelaShape®, Nordlys®, and other laser-based platforms. Acquired by Apax Partners in July 2017, the Company markets, services and supports its products in 86 countries. It has offices in the United States, Australia, Canada, China, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Portugal, Spain and the United Kingdom and many international distributors.

1. Bernstein EF, Schomacker K, Paranjape A, Jones CJ. Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam. Lasers Surg Med. 2018;doi:10.1002/lsm.22819

Media Contact:
Viviana M. Rueda
P: 615-918-0074 | E: vrueda@uniteddermpartners.com

EvolveMKD
P: 646-517-4220 | E: Candela@evolveMKD.com

/EIN News/ -- Candela_Logo_tagline_hi-res.jpg

Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.